Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04477187
Other study ID # STU-2020-0593
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2020
Est. completion date December 22, 2022

Study information

Verified date November 2023
Source University of Texas Southwestern Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of bipolar fractional radiofrequency treatment via use of the Profound System to achieve skin tightening and contour change in lax submental (beneath the chin) tissue.


Description:

This is a single-center, unblinded, non-randomized, non-controlled study designed to follow a total of up to 15 qualified and consenting subjects to receive one bipolar fractional radiofrequency microneedling treatment under an IRB approved protocol. Up to 15 subjects will be enrolled and treated at UT Southwestern in the Department of Plastic Surgery. Subjects will be identified from the clinical practice of Dr. Jeffrey Kenkel, Department of Plastic Surgery.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date December 22, 2022
Est. primary completion date June 13, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion Criteria: - Healthy male and female adults between ages 21-70 years of age. - Desire skin laxity lift of the submental region. - Confirmed BMI = 35. - Subjects who can read, understand, and sign the Informed Consent Form. - Subjects willing and able to comply with all study requirements. - Fitzpatrick skin type I-VI. - Submental fat graded by the Investigator as = 1 using the Clinician-Reported Submental Fat Rating Scale - Subject is willing not to undergo any type of aesthetic procedure that could confound the study device treatment effects until he/she completes the study. Exclusion Criteria: - Active localized or systemic infections, that may alter wound healing. - Immunocompromised subjects. - Subjects with coagulation disorder. - History of skin photosensitivity disorders, or use of photosensitizing drugs (e.g., tetracycline or sulfa drugs). - Pregnant and/or lactating (All female volunteers will be advised about using birth control during the period of study). - Excessive skin laxity on the submental and neck (Submental Skin Laxity Grade: SMSLG 4, Appendix E), or other anatomical feature for which reduction in SMF which may, in the judgment of the investigator, result in an aesthetically unacceptable outcome. - Scarring in areas to be treated. - Tattoos in the treatment areas to be treated. - Significant open facial wounds or lesions. - Severe or cystic acne in treatment areas. - Current active smoker. - Use of Accutane (Isotretinoin) within the past 6 months. - Use of topical retinoids within 48 hours. - Use of prescription anticoagulants. - Pacemaker or internal defibrillator. - History of skin disorders resulting in abnormal wound healing (i.e. keloids, extreme dry and fragile skin). - Subjects on current oral corticosteroid therapy or within the past 6 months - Metal implants in the treatment area. - In the opinion of the investigator, subject is unwilling or unable to adhere to all study requirements, including application and follow-up visits. - Subjects with a history of radiation therapy to the treatment area. - Subject has a history of allergy to lidocaine or ester-based local anesthetics. - Subjects with significant cardiac history or rhythm disturbance who may be unable to tolerate lidocaine with epinephrine. - Subjects with any skin pathology or condition in the treatment area that could interfere with evaluation or with the use of typical ancillary medical treatments or care used before, during or after treatments (e.g. psoriasis, rosacea, eczema, seborrheic dermatitis, vitiligo, hyper or hypo-skin pigmentation conditions such as post inflammatory hyperpigmentation). - Subjects who are unwilling to shave excessive hair in the treatment area that might influence or impair evaluation in the opinion of the Investigator. - Subjects have undergone skin resurfacing or tightening treatments in the treatment area over the past year. - Subjects have undergone dermatological treatments such as fillers and neurotoxins for the past 6 months in the treatment area. - Subjects have undergone laser and light treatments in the treatment area over the past 3 months. - Subjects have undergone superficial peel or microdermabrasion within 4 weeks.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Dermal Handpiece
Radiofrequency (RF) will travel through the RF generator through the electrodes and into the dermal layer beneath the surface of the skin. The microneedles of the dermal cartridges coupled with the thermal heat will stimulate neocollagenesis and neoelastosis, aiding in the reduction of submental laxity.

Locations

Country Name City State
United States UT Southwestern Medical Center- Dept of Plastic Surgery Dallas Texas

Sponsors (1)

Lead Sponsor Collaborator
University of Texas Southwestern Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent Change From Baseline of Soft Tissue Surface Area 3D stereophotogrammetry measurements obtained at Follow Up visits and compared to baseline measurements.
Percent change from baseline was calculated from baseline for both Month 3 and Month 6.
Month 3 and Month 6 Follow Up
Primary Percent Change From Baseline in Volume 3D stereophotogrammetry measurements obtained at Follow Up visits and compared to baseline measurements.
Percent change from baseline was calculated from baseline for both Month 3 and Month 6.
Month 3 and Month 6 Follow Up
Primary Percent Change in Minor Tissue Strain Percent change in Minor Tissue Strain is measured using the Markerless Tracking feature on Canfield's H2 3D Imaging System. 3D stereophotogrammetry measurements obtained at Follow Up visits and compared to baseline measurements.
Percent change from baseline was calculated from baseline for both Month 3 and Month 6.
Month 3 and Month 6 Follow Up
Primary Percent Change in Horizontal Displacement Percent change in Horizontal Displacement is measured using the Markerless Tracking feature on Canfield's H2 3D Imaging System. 3D stereophotogrammetry measurements obtained at Follow Up visits and compared to baseline measurements.
Percent change from baseline was calculated from baseline for both Month 3 and Month 6.
Month 3 and Month 6 Follow Up
Primary Percent Change in Vertical Displacement Percent change in Vertical Displacement is measured using the Markerless Tracking feature on Canfield's H2 3D Imaging System. 3D stereophotogrammetry measurements obtained at Follow Up visits and compared to baseline measurements.
Percent change from baseline was calculated from baseline for both Month 3 and Month 6.
Month 3 and Month 6 Follow Up
Secondary Improvement in Assessments: Global Aesthetic Improvement Score Blinded reviewers will assessment and score using a 5-point Global Aesthetic Improvement Score (1=Very Much Improved, 5= worse) Baseline - 6 Months (Day 180)
Secondary Subjects Assessment of Pain: Numerical Pain Rating Scale Immediately after the study procedure, subjects will be asked to rate any pain or discomfort using a 11-point Numerical Pain Rating Scale (0= No pain, 10= Extreme pain) Visit 2 (Day 0- immediately after study procedure)
Secondary Non-invasive Measurements: Transepidermal Water Loss Measurements Skin texture and laxity will be assessed using non invasive skin measurements.
Biox Aquaflux- will be used to measure transepidermal water loss.
Baseline, 3 Month and 6 Month Follow Up
Secondary Non-invasive Measurements: Optical Coherence Tomography (OCT) : [Ra, Rz] Skin texture and laxity will be assessed using non invasive skin measurements. Skin laxity and elasticity are measured using the Biomechanical Tissue Characterization System.
Optical coherence tomography (OCT) will be used to topographical and histological images of pre- and post-treated skin.
Ra, is the average measurement of skin curvatures and takes into all account variances in the skin roughness profile from the center line.
Rz, is the difference between the highest and lowest data points from the mean surface measurement.
Baseline, 3 months, 6 Months (Day 180)
Secondary Non-invasive Measurements: Optical Coherence Tomography (OCT): Attenuation Coefficient Skin texture and laxity will be assessed using non invasive skin measurements.
Optical coherence tomography (OCT) will be used to topographical and histological images of pre- and post-treated skin.
Attenuation coefficient (AC) is a measure of the decay of light intensity within the sample due to absorption and scattering.
Baseline, 3 months, 6 Months (Day 180)
Secondary Non-invasive Measurements : Biomechanical Tissue Measurements (Laxity, Elasticity) Skin laxity and elasticity will be assessed using non invasive skin measurements.
Bio-Mechanical Tissue Characterization (BTC2000)- will be used to measure skin laxity values of the skin. This is a laser measurement system for objective, quantitative and sensitive analyses of the bio-mechanical properties of: Skin laxity, elasticity.
Baseline, Month 3, Month 6
Secondary Non-invasive Measurements : Biomechanical Tissue Measurements (Elastic, Viscoelastic and Ultimate Deformation) Skin Elastic, Viscoelastic and Ultimate Deformation will be assessed using non invasive skin measurements.
Bio-Mechanical Tissue Characterization (BTC2000)- will be used to measure skin laxity values of the skin. This is a laser measurement system for objective, quantitative and sensitive analyses of the bio-mechanical properties of: Skin Elastic, Viscoelastic and Ultimate Deformation.
Baseline, Month 3, Month 6
Secondary Non-invasive Measurements : Biomechanical Tissue Measurements (Stiffness) Skin stiffness will be assessed using non invasive skin measurements.
Bio-Mechanical Tissue Characterization (BTC2000)- will be used to measure skin laxity values of the skin. This is a laser measurement system for objective, quantitative and sensitive analyses of the bio-mechanical properties of: Skin stiffness.
Baseline, Month 3, Month 6
Secondary Non-invasive Measurements : Biomechanical Tissue Measurements (Energy Absorption) Energy absorption will be assessed using non invasive skin measurements.
Bio-Mechanical Tissue Characterization (BTC2000)- will be used to measure skin laxity values of the skin. This is a laser measurement system for objective, quantitative and sensitive analyses of the bio-mechanical properties of: Skin - Energy absorption
Baseline, Month 3, Month 6
Secondary Change in Gene Expression at Month 3 Biopsies collected from subjects will be analyzed to observe changes from baseline to Month 3. Gene Expression studies cellular activity and Col1, Col3, ELN, Lox, IL8 are all biomarkers.
Fold Changes were compared to control and calculated from Ct values of RT-qPCR reactions.
Ct: threshold cycle
RT-qPCR: Quantitative reverse transcription polymerase chain reaction)
Baseline, Month 3
Secondary Change in Gene Expression at Month 6 Biopsies collected from subjects will be analyzed to observe changes from baseline to Month 6 . Gene Expression studies cellular activity and Col1, Col3, ELN, Lox, IL8 are all biomarkers.
Fold Changes were compared to control and calculated from Ct values of RT-qPCR reactions.
Ct: threshold cycle
RT-qPCR: Quantitative reverse transcription polymerase chain reaction)
Baseline, Month 6
Secondary Change in Histology at Month 3 All subjects will undergo a single treatment for skin laxity in the submentum with a dermal handpiece.
Dermal Handpiece: Radiofrequency (RF) will travel through the RF generator through the electrodes and into the dermal layer beneath the surface of the skin. The microneedles of the dermal cartridges coupled with the thermal heat will stimulate neocollagenesis and neoelastosis, aiding in the reduction of submental laxity.
Fold changes were compared to control and were calculated from fluorescence intensity of a confocal microscopy images.
Histology studies the structure of the tissue. Col3, Col1, ELN, Macrophage are biomarkers.
Baseline, Month 3
Secondary Change in Histology at Month 6 All subjects will undergo a single treatment for skin laxity in the submentum with a dermal handpiece.
Dermal Handpiece: Radiofrequency (RF) will travel through the RF generator through the electrodes and into the dermal layer beneath the surface of the skin. The microneedles of the dermal cartridges coupled with the thermal heat will stimulate neocollagenesis and neoelastosis, aiding in the reduction of submental laxity.
Histology studies the structure of the tissue. Col3, Col1, ELN, Macrophage are biomarkers.
Baseline, Month 6
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06140628 - A 28-day Clinical Study on Facial Skin Rejuvenation N/A
Completed NCT01971736 - Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening N/A
Completed NCT01713985 - Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck N/A
Completed NCT01708252 - Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment N/A
Completed NCT01708382 - Feasibility Study: Lifting and Tightening of the Elbows N/A
Completed NCT01713998 - Treatment of the Face and Neck With Lower Ulthera System Energy Settings N/A
Completed NCT04296201 - Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology N/A
Completed NCT06000839 - A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology) N/A
Completed NCT06366503 - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation N/A
Completed NCT05929625 - Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation N/A
Terminated NCT01713569 - Feasibility Study: Histological Characterization After Treatment With the Ulthera® System N/A
Completed NCT01519934 - A Retrospective Study to Evaluate the Effectiveness of the Ulthera System N/A
Completed NCT05605691 - Post-Market Lower Eyelid Treatment With Renuvion in Greece N/A
Completed NCT05590364 - Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands N/A
Active, not recruiting NCT06243744 - Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery N/A
Completed NCT04146584 - Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow Phase 2
Recruiting NCT05750901 - Evaluation of Fractional Ablative Laser Treatment for Skin Conditions N/A
Completed NCT04721600 - Evaluation of the Evoke Radiofrequency Device for Improvement of Skin Appearance N/A
Recruiting NCT06157567 - Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System N/A
Recruiting NCT05847530 - Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions N/A